Quantum Discovery
Quantum Discovery Labs is a technology based drug discovery company. We develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services, and pursue our own in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral and anti-cancer efficacy.
Quantum@linkedin.com
Contacts: office@q-pharm.com or comment any post on the site. You are welcome!
Quantum on Google+
cancer Archive
-
![The manuscript entitled “Transcription Factor DLX5 As a New Target for Promising Antitumor Agents” by the Quantum Team.
The reference:
R. A. Timakhov1,2,3*, P. O. Fedichev1, A. A. Vinnik1, J. R. Testa3, [...]](http://q-pharm.com/wp-content/uploads/2012/01/Screenshot-1-115x115.png "In-vitro study of DLX5 Ligands")
In-vitro study of DLX5 Ligands
Posted on January 26, 2012 | No CommentsThe manuscript entitled “Transcription Factor DLX5 As a New Target for Promising Antitumor Agents” by the Quantum Team. The reference: R. A. Timakhov1,2,3*, P. O. Fedichev1, A. A. Vinnik1, J. R. Testa3, [...] -
![The manuscript entitled “Transcription Factor DLX5 As a New Target for Promising Antitumor Agents” by the Quantum Team
The reference:
R. A. Timakhov1,2,3*, P. O. Fedichev1, A. A. Vinnik1, J. R. Testa3, [...]](http://q-pharm.com/wp-content/uploads/2012/01/Screenshot-61-115x115.png "High Throughput Screening of Transcription factor DLX5")
High Throughput Screening of Transcription factor DLX5
Posted on January 26, 2012 | No CommentsThe manuscript entitled “Transcription Factor DLX5 As a New Target for Promising Antitumor Agents” by the Quantum Team The reference: R. A. Timakhov1,2,3*, P. O. Fedichev1, A. A. Vinnik1, J. R. Testa3, [...] -
![Normally siRNA do not penetrate cell membranes without transfection reagents. In Quantum Pharmaceutical we developed a new nanoscale complex with ability to transport siRNA over cell membranes of a cancer [...]](http://q-pharm.com/wp-content/uploads/2010/05/siRNA2.png "Experimental siRNA complex uptake without transfection reagents")
Experimental siRNA complex uptake without transfection reagents
Posted on November 12, 2009 | 1 CommentNormally siRNA do not penetrate cell membranes without transfection reagents. In Quantum Pharmaceutical we developed a new nanoscale complex with ability to transport siRNA over cell membranes of a cancer [...] -
![Moscow, October, 28 2008
Quantum announce drug discovery collaboration with Children’s Cancer Institute Australia’s (CCIA). Under the terms of the agreement Quantum gets access to CCIA in-house disease target data. Quantum [...]](http://q-pharm.com/wp-content/themes/arras-theme/images/thumbnail.png "Quantum enters collaboration with Children’s Cancer Institute Australia")
Quantum enters collaboration with Children’s Cancer Institute Australia
Posted on October 28, 2008 | No CommentsMoscow, October, 28 2008 Quantum announce drug discovery collaboration with Children’s Cancer Institute Australia’s (CCIA). Under the terms of the agreement Quantum gets access to CCIA in-house disease target data. Quantum [...] -
Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.
Posted on September 12, 2008 | No CommentsQuantum announce drug discovery collaboration with Fox Chase Cancer Center Under the terms of agreement Quantum will apply its state-of-the-art in-house drug discovery technology to discover novel small molecule inhibitors [...]